Thank you for choosing ACROBiosystems. Would you rate our product and service？
Participate in the survey and you will have the chance to win the gift of your choice!
Thank you for choosing ACROBiosystems. Would you rate our product and service？
Participate in the survey and you will have the chance to win the gift of your choice!
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| PTR-H5222 | Human | Human PTH1R / PTHR1 Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Teriparatide biosimilar (Biosidus) | rhPTH (1-34) (Biosidus) | Approved | Biosidus | Osteofortil | Ecuador | Osteoporosis | Biosidus | 2012-08-01 | Osteoporosis | Details |
| Teriparatide biosimilar (Zydus Cadila) | rhPTH (1-34) (Zydus Cadila) | Approved | Zydus Cadila | India | Osteoporosis | Zydus Cadila | 2014-01-01 | Osteoporosis | Details | |
| Teriparatide biosimilar (STADA Arzneimittel AG) | rhPTH (1-34) (STADA Arzneimittel AG) | Approved | Stada Arzneimittel Ag | Movymia | EU | Osteoporosis | Stada Arzneimittel Ag | 2017-01-11 | Osteoporosis | Details |
| Teriparatide biosimilar (Gedeon Richter) | rhPTH (1-34) (Gedeon Richter) | Approved | Gedeon Richter Plc | Terrosa | EU | Osteoporosis | Gedeon Richter Plc | 2017-01-04 | Osteoporosis | Details |
| Teriparatide biosimilar (Salubris) | Approved | Shenzhen Salubris Pharmaceuticals Co Ltd | 欣复泰 | Mainland China | Osteoporosis, Postmenopausal | Suzhou Genemen Biotech Co Ltd | 2019-09-29 | Osteoporosis, Postmenopausal | Details | |
| Teriparatide biosimilar (USV) | Approved | Usv | Osteoporosis | Details | ||||||
| Teriparatide biosimilar (Intas Pharmaceuticals) | rhPTH (1-34) (Intas Pharmaceuticals) | Approved | Intas Biopharmaceuticals | Terifrac | India | Osteoporosis | Intas Biopharmaceuticals | 2010-12-01 | Osteoporosis | Details |
| Teriparatide biosimilar (CinnaGen) | rhPTH (1-34) (CinnaGen) | Approved | Cinnagen | CinnoPar | Iran | Osteoporosis | Cinnagen | 2013-01-01 | Osteoporosis | Details |
| Teriparatide biosimilar (Pfenex) | rhPTH (1-34) (Pfenex); PF-708 | Approved | Pfenex | Qutavina, Bonsity | United States | Osteoporosis | Alvogen | 2019-10-04 | Osteoporosis | Details |
| Teriparatide biosimilar (Virchow/Sun) | rhPTH (1-34) (Virchow/Sun) | Approved | Virchow Group, Sun Pharmaceutical Industries Ltd | Bonista, Osteotide | Osteoporosis | Details | ||||
| Teriparatide biosimilar (Theramex) | Approved | Theramex Ireland Ltd | Livogiva | EU | Osteoporosis | Theramex Ireland Ltd | 2020-08-27 | Osteoporosis | Details | |
| Recombinant Human Parathyroid Hormone (1-34), Shanghai Fosunpharma | Approved | Shanghai Fosun Pharmaceutical (Group) Co Ltd | Details | |||||||
| Abaloparatide | BA-058-SC; BA-058-TD; BIM-44058; BA-058; ITM-058 | Approved | Ipsen | Tymlos | Japan | Osteoporosis, Postmenopausal | Teijin Pharma | 2017-04-28 | Osteoporotic Fractures; Osteoporosis; Osteoporosis, Postmenopausal | Details |
| Parathyroid hormone (Shire) | 423562; ALX-111; SHP-634; SHP-635; NPSP-558; NPSP-795; PTH 1-84; SB-423562; PTH (1-84); rhPTH-1-84; rhPTH (1-84) | Approved | Shire | Natpar, Natpara, Preotact | EU | Hypoparathyroidism | Shire Pharmaceuticals Ireland Ltd | 2006-04-24 | Osteoporosis; Osteoporosis, Postmenopausal; Hypoparathyroidism | Details |
| Teriparatide acetate | hPTH (1-34) acet. H2O; AK-159; MN-10-T | Approved | Union Square Ventures Llc | Parathar, Teribone | Japan | Hypocalcemia; Osteoporosis | null | 1987-03-31 | Osteoporosis; Hypocalcemia | Details |
| Teriparatide biosimilar (Amega Biotech) | rhPTH (1-34) (Amega Biotech) | Approved | Amega Biotech | Osteoporosis | Details | |||||
| Teriparatide | MN-10T; hPTH-1-34; LY 333334 | Approved | Eli Lilly And Company | Forteo, Forsteo, 复泰奥 | Mainland China | Osteoporosis, Postmenopausal; Osteoporosis | Eli Lilly Nederland Bv | 2002-11-26 | Drug-Related Side Effects and Adverse Reactions; Osteoporotic Fractures; Osteoporosis; Bone Diseases, Metabolic; Osteoporosis, Postmenopausal; Colles' Fracture; Femoral Neck Fractures; Spinal Fractures; Back Pain; Hypoparathyroidism | Details |
| Teriparatide biosimilar (Shanghai United Cell ） | Approved | Shanghai United Cell Biotechnology Co Ltd | Mainland China | Osteoporosis | Shanghai United Cell Biotechnology Co Ltd | 2017-03-22 | Osteoporosis | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Teriparatide biosimilar (Stelis) | SBL-001 | Phase 1 Clinical | Stelis Biopharma | Osteoporosis | Details |
| Teriparatide transdermal (Corium International) | Phase 2 Clinical | Corium International Inc | Osteoporosis | Details | |
| KUR-111 | I-0401; KUR-111 | Phase 2 Clinical | Kuros Biosciences | Fractures, Bone | Details |
| Teriparatide (Critical Pharmaceuticals) | CP-046 | Phase 1 Clinical | University Of Nottingham, Critical Pharmaceuticals | Osteoporosis | Details |
| BMD-1221 | BMD-1221 | Clinical | University Of Arkansas System | Fractures, Bone | Details |
| T3-sulfate (Bracco SpA) | Phase 2 Clinical | Bracco | Hypothyroidism | Details | |
| Teriparatide biosimilar (Shanghai CAS Shenglongda Biotech) | Phase 3 Clinical | Shanghai Zhongke Shenglongda Biotechnology (Group) Co Ltd | Osteoporosis, Postmenopausal | Details | |
| Hemoparatide | hPTH-137 | Phase 1 Clinical | Pharis Biotec | Psoriasis | Details |
| Teriparatide biosimilar (National Institute of Dental and Craniofacial Research) | rhPTH (1-34) (National Institute of Dental and Craniofacial Research) | Phase 3 Clinical | National Institute Of Dental And Craniofacial Research | DiGeorge Syndrome; Hypothyroidism | Details |
| Teriparatide biosimilar (Shanghai Fudan-Zhangjiang Bio-Pharmaceutical) | Phase 1 Clinical | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd | Osteoporosis | Details | |
| Recombinant human parathyroid hormone (Shenzhen Salubris Pharmaceuticals) | SAL-001; G56-W1; rhPTH(1-34) | Phase 2 Clinical | Shenzhen Salubris Pharmaceuticals Co Ltd | Osteoporosis; Osteoporosis, Postmenopausal | Details |
| Teriparatide biosimilar (Dongguan Baolijian Bioengineer) | Phase 3 Clinical | Dongguan Baolijian Bioengineering Research And Development Co Ltd | Osteoporosis; Osteoporosis, Postmenopausal | Details | |
| KUR-113 | KUR-113; I-040202; Fibrin-PTH | Phase 2 Clinical | Kuros Biosciences | Spinal Diseases; Intervertebral Disc Degeneration; Fractures, Bone | Details |
| Parathyroid hormone 1-84 (Kerun Biopharmaceutical) | Phase 3 Clinical | Chongqing Kerun Biologic Pharmaceutical Development Co Ltd | Osteoporosis, Postmenopausal; Hypoparathyroidism | Details | |
| Recombinant Human Parathyroid Hormone (1-34)(Shanghai Celgen Biopharmaceuticals) | Phase 2 Clinical | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Osteoporosis | Details | |
| Recombinant Teriparatide(Beijing Bokangjian Gene) | Phase 1 Clinical | Beijing Bokangjian Gene Technology Co Ltd | Osteoporosis, Postmenopausal | Details | |
| TransCon PTH | ACP-014 | Phase 3 Clinical | Ascendis Pharma | Parathyroid Diseases; Hypoparathyroidism | Details |
| MT-1013 | MT-1013 | Phase 1 Clinical | Shaanxi Micot Technology Co Ltd | Hyperparathyroidism, Secondary | Details |
This web search service is supported by Google Inc.
A-Z